Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
reported being bedridden and having her limbs stiffen making it difficult to move; This is a spontaneous report received from a Consumer or other non HCP. A female patient (unknown if pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (disability), outcome "recovered" (04Sep2025), described as "reported being bedridden and having her limbs stiffen making it difficult to move". It was unknown if therapeutic measures were taken as a result of musculoskeletal stiffness. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.